Search

everythinglearnresearchcommunity

for

Search:↓

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Exosomes could be a promising way to help repair skin and treat skin disorders.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Cordyceps militaris is a promising, cost-effective medicinal fungus with health benefits and efficient production methods.

Kampo medicine can help treat general fatigue from long COVID.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.